{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:46:54Z","timestamp":1778881614782,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.bbmt.2018.02.007","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T03:03:02Z","timestamp":1519095782000},"page":"1209-1215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience"],"prefix":"10.1016","volume":"24","author":[{"given":"Musa","family":"Alzahrani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryse","family":"Power","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser","family":"Abou Mourad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raewyn","family":"Broady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Gerrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Hogge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Nantel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sanford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Toze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Nevill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujaatha","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2018.02.007_bib0010","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissue","author":"Swerdlow","year":"2008"},{"issue":"6","key":"10.1016\/j.bbmt.2018.02.007_bib0015","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"issue":"30","key":"10.1016\/j.bbmt.2018.02.007_bib0020","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","article-title":"Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making","volume":"23","author":"Malcovati","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.bbmt.2018.02.007_bib0025","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/cncr.23697","article-title":"Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System","volume":"113","author":"Kantarjian","year":"2008","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.bbmt.2018.02.007_bib0030","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised International Prognostic Scoring System for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bbmt.2018.02.007_bib0035","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias: French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.bbmt.2018.02.007_bib0040","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1182\/blood-2003-12-4207","article-title":"Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning","volume":"104","author":"Ho","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.02.007_bib0045","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-017-2429-z","article-title":"Reduced-intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis","author":"Zhang","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.bbmt.2018.02.007_bib0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.hoc.2010.02.003","article-title":"Hematopoietic stem cell transplantation for MDS","volume":"24","author":"Bartenstein","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.bbmt.2018.02.007_bib0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2147\/tcrm.2006.2.4.377","article-title":"Azacytidine (Vidaza) in the treatment of myelodysplastic syndromes","volume":"2","author":"Raj","year":"2006","journal-title":"Ther Clin Risk Manag"},{"issue":"8","key":"10.1016\/j.bbmt.2018.02.007_bib0060","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.bbmt.2012.01.009","article-title":"Pre-transplant therapy with azacitidine versus induction chemotherapy and post-transplant outcome in patients with MDS","volume":"18","author":"Gerds","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.bbmt.2018.02.007_bib0065","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood.V108.11.3664.3664","article-title":"Pre-transplant 5-azacitidine (Vidaza) may improve outcome of allogeneic hematopoietic cell transplantation (HCT) in patients with myelodysplastic syndrome (MDS)","volume":"108","author":"Field","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbmt.2018.02.007_bib0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbmt.2008.10.012","article-title":"Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden","volume":"15","author":"Warlick","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.bbmt.2018.02.007_bib0075","doi-asserted-by":"crossref","first-page":"12342","DOI":"10.18632\/oncotarget.12511","article-title":"Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blasts","volume":"8","author":"Yahng","year":"2017","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.bbmt.2018.02.007_bib0080","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood-2013-12-542720","article-title":"Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R","volume":"123","author":"Della Porta","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.02.007_bib0085","author":"Labopin"},{"key":"10.1016\/j.bbmt.2018.02.007_bib0090","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2018.02.007_bib0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.leukres.2011.09.007","article-title":"Time changes in predictive power of established and recently proposed clinical, cytogenetical and comorbidity scores for myelodysplastic syndromes","volume":"36","author":"Pfeilst\u00f6cker","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2018.02.007_bib0100","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood-2016-02-700054","article-title":"Time-dependent changes in mortality and transformation risk in MDS","volume":"128","author":"Pfeilst\u00f6cker","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.02.007_bib0105","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V122.21.1544.1544","article-title":"Time changes in predictive power of MDS prognostic scores: effects on revised scores such as the IPSS-R, impact of age","volume":"122","author":"Pfeilst\u00f6cker","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.02.007_bib0110","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.02.007_bib0115","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ajh.23513","article-title":"Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia","volume":"88","author":"Jabbour","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2018.02.007_bib0120","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s12185-014-1549-3","article-title":"Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromes","volume":"99","author":"Kim","year":"2014","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2018.02.007_bib0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ejh.12214","article-title":"Positive impact of chronic graft-versus-host disease on the outcome of patients with de novo myelodysplastic syndrome after allogeneic hematopoietic cell transplantation: a single-center analysis of 115 patients","volume":"92","author":"Hiramoto","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2018.02.007_bib0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/asheducation-2013.1.56","article-title":"Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence","volume":"2013","author":"van Besien","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.bbmt.2018.02.007_bib0135","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/sj.leu.2403343","article-title":"Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate","volume":"18","author":"Kanda","year":"2004","journal-title":"Leukemia"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118300855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118300855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:01:20Z","timestamp":1761058880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879118300855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1083879118300855"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.02.007","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}